Papel del índice de Charlson en el pronóstico a 30 días y 1 año tras un infarto agudo de miocardioPrognostic Value of Charlson Comorbidity Index at 30 Days and 1 Year After Acute Myocardial Infarction
Biblografía (28)
- et al.
Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005
Rev Esp Cardiol
(2002) Are you ever too old to be risk stratified?
J Am Coll Cardiol
(1992)- et al.
Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials?
Evidence from the GUSTO-1 study. Am Heart J
(2003) - et al.
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
Am Heart J
(2003) - et al.
Post-myocardial infarction risk stratification in elderly patients
Am Heart J
(2001) - et al.
How should age affect management of acute myocardial infarction?
A prospective cohort study. Lancet
(1999) - et al.
How to measure comorbidity. A critical review of available methods
J Clin Epidemiol
(2003) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project
J Am Coll Cardiol
(2001) - et al.
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
J Am Coll Cardiol
(2001)
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease
J Am Coll Cardiol
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective
J Am Coll Cardiol
Tasa de incidencia y mortalidad poblacional y hospitalaria del IAM en los mayores de 74 años en Gerona [resumen]
Rev Esp Cardiol
The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making
JAMA
Cited by (83)
Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry
2022, International Journal of CardiologyPrognostic Value of Charlson Comorbidity Index in Acute Embolic Lower Limb Ischaemia Patients
2021, Annals of Vascular SurgeryDevelopment and validation of a model for predicting 18-month mortality in type 2 myocardial infarction
2021, American Journal of Emergency MedicineCitation Excerpt :We used hemoglobin concentration as a continuous variable instead of anemia to improve performance of the developed model. The influence of comorbidity as classified by the CCI on survival in patients with MI was demonstrated in several studies [26,35-37], for example, Schmidt et al. examined the association between comorbidity and mortality among 234,331 patients with a first time hospitalization for MI from 1984 through 2008 [35]. Their reported association between comorbidity and 30 day (adjusted hazard ratio [aHR] 1.35 (95% CI 1.26–1.45) for moderate (CCI = 1) and 1.96 (95% CI 1.83–2.11) for very severe comorbidity (CCI ≥3)), one year mortality (aHR 1.83 (95% CI 1.68–2.00) for moderate and 3.89 (95% CI 3.58–4.24) for severe comorbidity).
Impact of Charlson Co-Morbidity Index Score on Management and Outcomes After Acute Coronary Syndrome
2020, American Journal of CardiologyCitation Excerpt :When patients with no co-morbidities (CCI = 0) were compared with patients with CCI = 1, 2, and ≥3 co-morbidities, the risk of mortality increased by 31%, 45%, and 74%, respectively. Previously our large meta-analysis3 of studies9–13,18–21 evaluating the impact of CCI score on cardiovascular diseases demonstrated that among ACS patients the risk of mortality was significantly higher with an incremental increase in CCI score. Three studies10,13,21 demonstrated that patients with any co-morbidities (CCI >0) had nearly 2 times the risk of death (relative risk 1.93; 95% CI 1.67 to 2.24) compared with those with CCI = 0.3